Vifor Fresenius Medical Care Renal Pharma 보도자료 - 뉴스와이어

기업 뉴스룸

Vifor Fresenius Medical Care Renal Pharma

제약

ST GALLEN, Switzerland & STAMFORD, Conn.

Vifor Fresenius Medical Care Renal Pharma 보도자료

메일구독 RSS

3개

2022년 8월 18일 16:40

Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a rituximab or cyclophosphamide regimen for the treatmen...

건강 제약 바이오테크 개발

2020년 12월 22일 10:26

VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)

Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and ChemoCentryx, Inc. today announced topline data from the ACCOLADE clinical study, the largest, randomized, blinded, placebo-controlled phase-II trial in the ultra-rare kidney ...

건강 제약 개발

2020년 4월 21일 16:32

VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus

Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced positive topline data from Cara’s KALM-2 pivotal phase-III trial of KORSUVA™ (CR845/difelikefalin) Injection in haemodial...

건강 제약 개발